Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9971, pp. 875 - 882
Summary Background Duration of treatment for patients with vertebral osteomyelitis is mainly based on expert recommendation rather than evidence. We aimed to...
Internal Medicine | MEDICINE, GENERAL & INTERNAL | INFECTIONS | SPONDYLITIS | OUTCOMES | DURATION | FRANCE | FEATURES | Single-Blind Method | Spinal Diseases - microbiology | Drug Administration Schedule | Humans | Middle Aged | Male | Treatment Outcome | Spinal Diseases - drug therapy | Spinal Diseases - pathology | Osteomyelitis - drug therapy | Anti-Bacterial Agents - therapeutic use | Osteomyelitis - microbiology | Osteomyelitis - pathology | Female | Aged | Anti-Bacterial Agents - adverse effects | Drug Therapy, Combination | Anti-Bacterial Agents - administration & dosage | Osteomyelitis | Care and treatment | Hospitals | Antibiotics | Clinical trials | Cross infection | Nosocomial infections | France | Back pain | Infections | Bone diseases | Biopsy | Medical treatment
Internal Medicine | MEDICINE, GENERAL & INTERNAL | INFECTIONS | SPONDYLITIS | OUTCOMES | DURATION | FRANCE | FEATURES | Single-Blind Method | Spinal Diseases - microbiology | Drug Administration Schedule | Humans | Middle Aged | Male | Treatment Outcome | Spinal Diseases - drug therapy | Spinal Diseases - pathology | Osteomyelitis - drug therapy | Anti-Bacterial Agents - therapeutic use | Osteomyelitis - microbiology | Osteomyelitis - pathology | Female | Aged | Anti-Bacterial Agents - adverse effects | Drug Therapy, Combination | Anti-Bacterial Agents - administration & dosage | Osteomyelitis | Care and treatment | Hospitals | Antibiotics | Clinical trials | Cross infection | Nosocomial infections | France | Back pain | Infections | Bone diseases | Biopsy | Medical treatment
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 59, Issue 22, pp. 1968 - 1976
Objectives The goal of this study was to evaluate temporal trends in infective endocarditis (IE) incidence and clinical characteristics after 2002 French IE...
Cardiovascular | Internal Medicine | staphylococci | epidemiology | infective endocarditis | prophylaxis | population-based | Infective endocarditis | Endocarditis | Studies | Confidence intervals | Prostheses | Hospitals | Disease | Heart surgery | Mortality | Classification | Hospitalization | Trends | Family medical history | Age
Cardiovascular | Internal Medicine | staphylococci | epidemiology | infective endocarditis | prophylaxis | population-based | Infective endocarditis | Endocarditis | Studies | Confidence intervals | Prostheses | Hospitals | Disease | Heart surgery | Mortality | Classification | Hospitalization | Trends | Family medical history | Age
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 5, pp. 510 - 519
Summary Background Listeriosis is a severe foodborne infection and a notifiable disease in France. We did a nationwide prospective study to characterise its...
Infectious Disease | MORTALITY | MENINGITIS | INFECTIOUS DISEASES | MONOCYTOGENES | RISK-FACTORS | MANAGEMENT | GUIDELINES | SURVEILLANCE | PREGNANCY | Foodborne Diseases - microbiology | Infant, Newborn, Diseases - epidemiology | Prognosis | Prospective Studies | Humans | Listeriosis - diagnosis | Bacteremia - mortality | Male | Infant, Newborn, Diseases - microbiology | Listeriosis - epidemiology | Mandatory Reporting | Listeria monocytogenes - classification | Adult | Female | Pregnancy Complications, Infectious - microbiology | Infant, Newborn | Meningoencephalitis - epidemiology | France - epidemiology | Meningoencephalitis - mortality | Pregnancy Complications, Infectious - epidemiology | Risk Factors | Listeria monocytogenes - isolation & purification | Hospitalization | Infectious Disease Transmission, Vertical | Pregnancy | Meningoencephalitis - microbiology | Bacteremia - epidemiology | Listeriosis - microbiology | Aged | Population Surveillance | Listeriosis | Neonates | Food-borne diseases | Disease | Brain stem | Clinical trials | Infections | Genomes | Gestation | Epidemiology | Risk factors | Windows (intervals) | Listeria | Meningitis | Public health | Food | Dexamethasone | Bacterial infections | Mortality | Fetuses | Regression analysis | Clustering | Patients | Bacteremia | Meningoencephalitis | Studies | Surveillance | Medical prognosis | Health risk assessment | Cancer | Life Sciences
Infectious Disease | MORTALITY | MENINGITIS | INFECTIOUS DISEASES | MONOCYTOGENES | RISK-FACTORS | MANAGEMENT | GUIDELINES | SURVEILLANCE | PREGNANCY | Foodborne Diseases - microbiology | Infant, Newborn, Diseases - epidemiology | Prognosis | Prospective Studies | Humans | Listeriosis - diagnosis | Bacteremia - mortality | Male | Infant, Newborn, Diseases - microbiology | Listeriosis - epidemiology | Mandatory Reporting | Listeria monocytogenes - classification | Adult | Female | Pregnancy Complications, Infectious - microbiology | Infant, Newborn | Meningoencephalitis - epidemiology | France - epidemiology | Meningoencephalitis - mortality | Pregnancy Complications, Infectious - epidemiology | Risk Factors | Listeria monocytogenes - isolation & purification | Hospitalization | Infectious Disease Transmission, Vertical | Pregnancy | Meningoencephalitis - microbiology | Bacteremia - epidemiology | Listeriosis - microbiology | Aged | Population Surveillance | Listeriosis | Neonates | Food-borne diseases | Disease | Brain stem | Clinical trials | Infections | Genomes | Gestation | Epidemiology | Risk factors | Windows (intervals) | Listeria | Meningitis | Public health | Food | Dexamethasone | Bacterial infections | Mortality | Fetuses | Regression analysis | Clustering | Patients | Bacteremia | Meningoencephalitis | Studies | Surveillance | Medical prognosis | Health risk assessment | Cancer | Life Sciences
Journal Article
4.
Full Text
Staphylococcus aureus bloodstream infection and endocarditis - A prospective cohort study
PLoS ONE, ISSN 1932-6203, 05/2015, Volume 10, Issue 5, p. e0127385
Objectives To update the epidemiology of Staphylococcus aureusbloodstream infection (SAB) in a high-income country and its link with infective endocarditis...
MORTALITY | METHICILLIN RESISTANCE | DIAGNOSIS | RISK-FACTORS | BACTEREMIA | MULTIDISCIPLINARY SCIENCES | GUIDELINES | PROGRESS | COMPLICATIONS | ECHOCARDIOGRAPHY | France - epidemiology | Prospective Studies | Hospital Mortality | Pneumonia, Staphylococcal - blood | Endocarditis, Bacterial - mortality | Humans | Middle Aged | Risk Factors | Bacteremia - mortality | Male | Pneumonia, Staphylococcal - mortality | Endocarditis, Bacterial - blood | Aged, 80 and over | Bacteremia - blood | Endocarditis, Bacterial - microbiology | Adult | Female | Aged | Staphylococcus aureus | Complications and side effects | Care and treatment | Pneumonia | Cardiac patients | Patient outcomes | Bacterial pneumonia | Staphylococcus aureus infections | Development and progression | Research | Health aspects | Health care | Prostheses | Nosocomial infection | Drug abuse | C-reactive protein | Communities | Income | Nervous system | Infections | Epidemiology | Risk factors | Methicillin | Confidence intervals | Antibiotic resistance | Meningitis | Nosocomial infections | Rheumatic heart disease | Heart diseases | Mortality | Staphylococcus infections | Septic shock | Patients | Coronary artery disease | Bacteremia | Studies | Hospitals | Antibiotics | Endocarditis | Sepsis | Life Sciences | Human health and pathology | Santé publique et épidémiologie | Infectious diseases
MORTALITY | METHICILLIN RESISTANCE | DIAGNOSIS | RISK-FACTORS | BACTEREMIA | MULTIDISCIPLINARY SCIENCES | GUIDELINES | PROGRESS | COMPLICATIONS | ECHOCARDIOGRAPHY | France - epidemiology | Prospective Studies | Hospital Mortality | Pneumonia, Staphylococcal - blood | Endocarditis, Bacterial - mortality | Humans | Middle Aged | Risk Factors | Bacteremia - mortality | Male | Pneumonia, Staphylococcal - mortality | Endocarditis, Bacterial - blood | Aged, 80 and over | Bacteremia - blood | Endocarditis, Bacterial - microbiology | Adult | Female | Aged | Staphylococcus aureus | Complications and side effects | Care and treatment | Pneumonia | Cardiac patients | Patient outcomes | Bacterial pneumonia | Staphylococcus aureus infections | Development and progression | Research | Health aspects | Health care | Prostheses | Nosocomial infection | Drug abuse | C-reactive protein | Communities | Income | Nervous system | Infections | Epidemiology | Risk factors | Methicillin | Confidence intervals | Antibiotic resistance | Meningitis | Nosocomial infections | Rheumatic heart disease | Heart diseases | Mortality | Staphylococcus infections | Septic shock | Patients | Coronary artery disease | Bacteremia | Studies | Hospitals | Antibiotics | Endocarditis | Sepsis | Life Sciences | Human health and pathology | Santé publique et épidémiologie | Infectious diseases
Journal Article
Clinical Microbiology and Infection, ISSN 1198-743X, 2018, Volume 25, Issue 4, pp. 481 - 488
Objectives: Time to blood culture positivity (TTP), a routinely available parameter in automated blood culture systems, may be a proxy for infectious burden in...
Infective endocarditis | Bacteraemia | Mortality | Staphylococcus aureus | Time to blood culture positivity | DIAGNOSIS | INFECTIOUS DISEASES | DIFFERENTIAL TIME | RISK-FACTORS | MICROBIOLOGY | STREAM INFECTIONS | TRENDS | Prospective Studies | Endocarditis, Bacterial - mortality | Humans | Middle Aged | Endocarditis, Bacterial - diagnosis | Male | Bacteremia - diagnosis | Bacteremia - microbiology | Staphylococcal Infections - diagnosis | Time Factors | Bacteremia - blood | Endocarditis, Bacterial - microbiology | Female | Aged | Staphylococcal Infections - microbiology | Blood Culture - statistics & numerical data | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Staphylococcal Infections - blood | Life Sciences | Microbiology and Parasitology
Infective endocarditis | Bacteraemia | Mortality | Staphylococcus aureus | Time to blood culture positivity | DIAGNOSIS | INFECTIOUS DISEASES | DIFFERENTIAL TIME | RISK-FACTORS | MICROBIOLOGY | STREAM INFECTIONS | TRENDS | Prospective Studies | Endocarditis, Bacterial - mortality | Humans | Middle Aged | Endocarditis, Bacterial - diagnosis | Male | Bacteremia - diagnosis | Bacteremia - microbiology | Staphylococcal Infections - diagnosis | Time Factors | Bacteremia - blood | Endocarditis, Bacterial - microbiology | Female | Aged | Staphylococcal Infections - microbiology | Blood Culture - statistics & numerical data | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Staphylococcal Infections - blood | Life Sciences | Microbiology and Parasitology
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 05/2014, Volume 14, Issue 1, pp. 287 - 287
Background: Current recommendations for empirical antimicrobial therapy in spontaneous bacterial peritonitis (SBP) are based on quite old trials. Since...
Resistance | Spontaneous bacterial peritonitis | Epidemiology | Antibiotic susceptibility | Bacterascites | INFECTIOUS DISEASES | INFECTIONS | MANAGEMENT | CEFTRIAXONE | PREVALENCE | CLAVULANIC ACID | ASCITIC FLUID | PROPHYLAXIS | PHARMACOKINETICS | CIRRHOTIC-PATIENTS | CEFOTAXIME | Bacterial Infections - drug therapy | Escherichia coli - drug effects | Humans | Middle Aged | Ascitic Fluid - microbiology | Anti-Infective Agents - therapeutic use | Male | Peritonitis - epidemiology | Treatment Outcome | Cross Infection - drug therapy | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Peritonitis - microbiology | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Cross Infection - microbiology | Escherichia coli - pathogenicity | Bacterial Infections - epidemiology | Female | Aged | Drug Resistance, Bacterial - drug effects | Cross Infection - epidemiology | Drug resistance in microorganisms | Research | Analysis | Peritonitis | Life Sciences | Human health and pathology | Microbiology and Parasitology
Resistance | Spontaneous bacterial peritonitis | Epidemiology | Antibiotic susceptibility | Bacterascites | INFECTIOUS DISEASES | INFECTIONS | MANAGEMENT | CEFTRIAXONE | PREVALENCE | CLAVULANIC ACID | ASCITIC FLUID | PROPHYLAXIS | PHARMACOKINETICS | CIRRHOTIC-PATIENTS | CEFOTAXIME | Bacterial Infections - drug therapy | Escherichia coli - drug effects | Humans | Middle Aged | Ascitic Fluid - microbiology | Anti-Infective Agents - therapeutic use | Male | Peritonitis - epidemiology | Treatment Outcome | Cross Infection - drug therapy | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Peritonitis - microbiology | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Cross Infection - microbiology | Escherichia coli - pathogenicity | Bacterial Infections - epidemiology | Female | Aged | Drug Resistance, Bacterial - drug effects | Cross Infection - epidemiology | Drug resistance in microorganisms | Research | Analysis | Peritonitis | Life Sciences | Human health and pathology | Microbiology and Parasitology
Journal Article